The AutoLITT® System is an investigational device, not yet tested in humans. Clinical studies are planned in 2008 and 2009 to explore the potential of the AutoLITT therapy to have distinct advantages in the treatment of brain tumors in certain situations, including:
•
Less risk of complications
•
Fewer side effects
•
Faster recovery
•
“Immediate” complete tumor death
•
Minimal or no damage to surrounding healthy brain tissue
Brain Cancer
